Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 104.96
MED's Cash to Debt is ranked higher than
89% of the 1286 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.84 vs. MED: 104.96 )
MED' s 10-Year Cash to Debt Range
Min: 0.06   Max: No Debt
Current: 104.96

Equity to Asset 0.72
MED's Equity to Asset is ranked higher than
91% of the 1280 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.47 vs. MED: 0.72 )
MED' s 10-Year Equity to Asset Range
Min: 0.26   Max: 0.8
Current: 0.72

0.26
0.8
F-Score: 5
Z-Score: 12.19
M-Score: -2.84
WACC vs ROIC
6.49%
69.42%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 9.12
MED's Operating margin (%) is ranked higher than
86% of the 1288 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.00 vs. MED: 9.12 )
MED' s 10-Year Operating margin (%) Range
Min: -44.4   Max: 14.83
Current: 9.12

-44.4
14.83
Net-margin (%) 6.85
MED's Net-margin (%) is ranked higher than
88% of the 1288 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.24 vs. MED: 6.85 )
MED' s 10-Year Net-margin (%) Range
Min: -68.63   Max: 33.43
Current: 6.85

-68.63
33.43
ROE (%) 22.05
MED's ROE (%) is ranked higher than
92% of the 1266 Companies
in the Global Specialty Retail industry.

( Industry Median: 8.68 vs. MED: 22.05 )
MED' s 10-Year ROE (%) Range
Min: -330.09   Max: 261.38
Current: 22.05

-330.09
261.38
ROA (%) 16.41
MED's ROA (%) is ranked higher than
96% of the 1292 Companies
in the Global Specialty Retail industry.

( Industry Median: 4.12 vs. MED: 16.41 )
MED' s 10-Year ROA (%) Range
Min: -51.27   Max: 49.76
Current: 16.41

-51.27
49.76
ROC (Joel Greenblatt) (%) 75.07
MED's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 1288 Companies
in the Global Specialty Retail industry.

( Industry Median: 16.81 vs. MED: 75.07 )
MED' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -130.05   Max: 83.14
Current: 75.07

-130.05
83.14
Revenue Growth (3Y)(%) 13.50
MED's Revenue Growth (3Y)(%) is ranked higher than
90% of the 1084 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.30 vs. MED: 13.50 )
MED' s 10-Year Revenue Growth (3Y)(%) Range
Min: -45.9   Max: 63.6
Current: 13.5

-45.9
63.6
EBITDA Growth (3Y)(%) 8.10
MED's EBITDA Growth (3Y)(%) is ranked higher than
78% of the 907 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.50 vs. MED: 8.10 )
MED' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 8.1   Max: 78.8
Current: 8.1

8.1
78.8
EPS Growth (3Y)(%) 8.60
MED's EPS Growth (3Y)(%) is ranked higher than
76% of the 852 Companies
in the Global Specialty Retail industry.

( Industry Median: 6.90 vs. MED: 8.60 )
MED' s 10-Year EPS Growth (3Y)(%) Range
Min: -12.1   Max: 68.9
Current: 8.6

-12.1
68.9
» MED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

MED Guru Trades in Q1 2014

Steven Cohen 10,301 sh (New)
Richard Snow 93,880 sh (+19.86%)
Chuck Royce 168,000 sh (unchged)
Paul Tudor Jones Sold Out
Jim Simons 260,684 sh (-23.42%)
» More
Q2 2014

MED Guru Trades in Q2 2014

John Burbank 7,506 sh (New)
Jim Simons 165,000 sh (-36.7%)
Richard Snow 53,900 sh (-42.59%)
Chuck Royce 60,000 sh (-64.29%)
» More
Q3 2014

MED Guru Trades in Q3 2014

Jim Simons 236,200 sh (+43.15%)
John Burbank 6,170 sh (-17.8%)
Richard Snow 39,500 sh (-26.72%)
Chuck Royce 800 sh (-98.67%)
» More
Q4 2014

MED Guru Trades in Q4 2014

Chuck Royce 2,200 sh (+175%)
Jim Simons 307,800 sh (+30.31%)
Richard Snow Sold Out
John Burbank Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Richard Snow 2014-12-31 Sold Out 0.05%$29.39 - $33.79 $ 31.642%0
John Burbank 2014-12-31 Sold Out $29.39 - $33.79 $ 31.642%0
Richard Snow 2014-09-30 Reduce -26.72%0.02%$26.15 - $34.98 $ 31.643%39500
Richard Snow 2014-06-30 Reduce -42.59%0.05%$28.88 - $34.08 $ 31.642%53900
John Burbank 2014-06-30 New Buy$28.88 - $34.08 $ 31.642%7506
Richard Snow 2013-12-31 Add 37.16%0.02%$23.31 - $27.49 $ 31.6424%78325
Richard Snow 2013-09-30 Add 28.35%0.02%$24.85 - $28.88 $ 31.6418%57105
Richard Snow 2013-03-31 New Buy0.05%$22.26 - $28.1 $ 31.6427%40700
Joel Greenblatt 2012-12-31 Sold Out 0.04%$25.41 - $32.28 $ 31.6411%0
Richard Snow 2012-09-30 Sold Out 0.03%$19.97 - $28.75 $ 31.6425%0
Joel Greenblatt 2012-09-30 Reduce -24.11%0.01%$19.97 - $28.75 $ 31.6425%25273
Joel Greenblatt 2012-06-30 Reduce -67.4%0.11%$16.46 - $19.82 $ 31.6472%33302
Joel Greenblatt 2012-03-31 Add 45.49%0.05%$14.78 - $17.73 $ 31.64105%102169
Richard Snow 2012-03-31 Add 115.55%0.01%$14.78 - $17.73 $ 31.64105%28410
Joel Greenblatt 2011-12-31 Add 31.87%0.03%$13.01 - $17.3 $ 31.64108%70224
Richard Snow 2011-12-31 New Buy0.01%$13.01 - $17.3 $ 31.64108%13180
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 19.10
MED's P/E(ttm) is ranked higher than
81% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 27.30 vs. MED: 19.10 )
MED' s 10-Year P/E(ttm) Range
Min: 8.98   Max: 61.03
Current: 19.1

8.98
61.03
Forward P/E 15.63
MED's Forward P/E is ranked higher than
84% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 24.04 vs. MED: 15.63 )
N/A
PE(NRI) 18.90
MED's PE(NRI) is ranked higher than
81% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 27.00 vs. MED: 18.90 )
MED' s 10-Year PE(NRI) Range
Min: 8.97   Max: 61.23
Current: 18.9

8.97
61.23
P/B 4.90
MED's P/B is ranked higher than
56% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.39 vs. MED: 4.90 )
MED' s 10-Year P/B Range
Min: 1.32   Max: 10.95
Current: 4.9

1.32
10.95
P/S 1.30
MED's P/S is ranked higher than
62% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.90 vs. MED: 1.30 )
MED' s 10-Year P/S Range
Min: 0.49   Max: 4.81
Current: 1.3

0.49
4.81
PFCF 16.30
MED's PFCF is ranked higher than
85% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 43.30 vs. MED: 16.30 )
MED' s 10-Year PFCF Range
Min: 8.43   Max: 165
Current: 16.3

8.43
165
POCF 12.66
MED's POCF is ranked higher than
77% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 16.20 vs. MED: 12.66 )
MED' s 10-Year POCF Range
Min: 5.47   Max: 1039
Current: 12.66

5.47
1039
EV-to-EBIT 11.22
MED's EV-to-EBIT is ranked higher than
86% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 18.35 vs. MED: 11.22 )
MED' s 10-Year EV-to-EBIT Range
Min: 4.8   Max: 41.2
Current: 11.22

4.8
41.2
PEG 0.76
MED's PEG is ranked higher than
96% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.00 vs. MED: 0.76 )
MED' s 10-Year PEG Range
Min: 0.2   Max: 2.07
Current: 0.76

0.2
2.07
Shiller P/E 24.20
MED's Shiller P/E is ranked higher than
83% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 50.33 vs. MED: 24.20 )
MED' s 10-Year Shiller P/E Range
Min: 12.14   Max: 94.08
Current: 24.2

12.14
94.08
Current Ratio 2.89
MED's Current Ratio is ranked higher than
91% of the 1287 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.56 vs. MED: 2.89 )
MED' s 10-Year Current Ratio Range
Min: 0.99   Max: 6.73
Current: 2.89

0.99
6.73
Quick Ratio 2.30
MED's Quick Ratio is ranked higher than
94% of the 1287 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.85 vs. MED: 2.30 )
MED' s 10-Year Quick Ratio Range
Min: 0.46   Max: 4.52
Current: 2.3

0.46
4.52
Days Inventory 76.00
MED's Days Inventory is ranked higher than
77% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 99.91 vs. MED: 76.00 )
MED' s 10-Year Days Inventory Range
Min: 79.66   Max: 258.67
Current: 76

79.66
258.67
Days Sales Outstanding 2.70
MED's Days Sales Outstanding is ranked higher than
92% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 22.48 vs. MED: 2.70 )
MED' s 10-Year Days Sales Outstanding Range
Min: 0.88   Max: 76.69
Current: 2.7

0.88
76.69

Valuation & Return

vs
industry
vs
history
Price/Net Cash 17.68
MED's Price/Net Cash is ranked higher than
96% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.00 vs. MED: 17.68 )
MED' s 10-Year Price/Net Cash Range
Min: 8.3   Max: 382.25
Current: 17.68

8.3
382.25
Price/Net Current Asset Value 12.31
MED's Price/Net Current Asset Value is ranked higher than
92% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.00 vs. MED: 12.31 )
MED' s 10-Year Price/Net Current Asset Value Range
Min: 6.77   Max: 434
Current: 12.31

6.77
434
Price/Tangible Book 4.88
MED's Price/Tangible Book is ranked higher than
62% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.44 vs. MED: 4.88 )
MED' s 10-Year Price/Tangible Book Range
Min: 1.11   Max: 22.96
Current: 4.88

1.11
22.96
Price/DCF (Projected) 1.02
MED's Price/DCF (Projected) is ranked higher than
87% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.10 vs. MED: 1.02 )
MED' s 10-Year Price/DCF (Projected) Range
Min: 1.02   Max: 11.53
Current: 1.02

1.02
11.53
Price/Median PS Value 1.04
MED's Price/Median PS Value is ranked higher than
77% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.13 vs. MED: 1.04 )
MED' s 10-Year Price/Median PS Value Range
Min: 0.18   Max: 4.86
Current: 1.04

0.18
4.86
Price/Peter Lynch Fair Value 1.87
MED's Price/Peter Lynch Fair Value is ranked higher than
89% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.00 vs. MED: 1.87 )
MED' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4   Max: 3.48
Current: 1.87

0.4
3.48
Price/Graham Number 2.00
MED's Price/Graham Number is ranked higher than
74% of the 1369 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.59 vs. MED: 2.00 )
MED' s 10-Year Price/Graham Number Range
Min: 0.17   Max: 5.64
Current: 2

0.17
5.64
Earnings Yield (Greenblatt) 8.80
MED's Earnings Yield (Greenblatt) is ranked higher than
85% of the 1286 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.80 vs. MED: 8.80 )
MED' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.4   Max: 20.7
Current: 8.8

2.4
20.7
Forward Rate of Return (Yacktman) 15.36
MED's Forward Rate of Return (Yacktman) is ranked higher than
83% of the 893 Companies
in the Global Specialty Retail industry.

( Industry Median: 10.45 vs. MED: 15.36 )
MED' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3   Max: 61.6
Current: 15.36

-3
61.6

Business Description

Industry: Retail - Apparel & Specialty » Specialty Retail
Compare:TSCO, AMZN, EBAY, FIVE, AZO » details
Traded in other countries:MDF.Germany,
Medifast Inc is a Delaware Corporation, incorporated in 1993. The Company is engaged in the productions, distributions, and sales of weight loss and weight management products and other consumable health and diet products. Its product lines include weight loss and management, meal replacement, and vitamins. Its products and services are sold to weight loss program participants via the Internet, telephone, and brick and mortar clinics. It operates in two reportable segments; Medifast, and MWCC and Wholesale. The Medifast segment consists of the sales from Medifast Direct Marketing and Take Shape For Life. The MWCC and Wholesale segment consists of the sales of Medifast Corporate and Franchise Weight Control Centers as well as Medifast Wholesale Physicians and international sales. Medifast Weight Control Centers is the brick and mortar clinic channel of the Company with affiliate-owned locations in Pennsylvania, New Jersey, Delaware, Texas, Florida, Maryland, North Carolina and Virginia. Medifast Weight Control Centers offer a high-touch model including comprehensive Companys programs for weight loss and maintenance, customized client counseling, an InBody body composition analysis, and monitoring with a BodyGem indirect calorimeter that determines resting metabolic rates. In the direct-to-consumer channel, Medifast Direct, customers order its product directly through the Companys website, www.medifast1.com or its in-house call center. Take Shape For Life is the personal coaching division of the Company. It enriches lives by providing clinically proven weight loss and weight management products and programs. It offers clinically proven products and programs for weight management, weight maintenance, and long-term health through multiple channels of distribution. It offers a variety of weight loss and weight management products under the Medifast and Essential 1 brands and for select private label customers. Its line includes more than 75 options, including, but not limited to bars, bites, pretzels, puffs, cereal crunch, drinks, eggs, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company continues to build and leverage its core brand through multiple marketing strategies for each of its distinct distribution channels such as Medifast Direct, Medical Wholesale, Medifast Weight Control Centers, and Take Shape For Life to their target audiences. It has also developed a comprehensive social media strategy utilizing Facebook, Twitter, YouTube, blogger endorsements, and more. The Company competes with NutriSystem Inc., Herbalife Ltd., USANA Health Sciences, and Weight Watchers International, Inc. The formulation, processing, packaging, and labeling of the Company's products is subject to regulation by several federal agencies, but principally by the FDA.
» More Articles for MED

Headlines

Articles On GuruFocus.com
This Company Focuses on Consumer Preferences in the Entire World Dec 17 2014 
Is It Time to Buy Avon? Dec 11 2014 
Medgold Options Portugal Licences to Centerra Gold Dec 09 2014 
Medgold Reports 69 m @ 4.15 g/t Au from Channel Sampling at the Lagares Gold Project, Portugal Dec 02 2014 
Small cap high short interest (Predictability = 5), Part 1 Oct 16 2014 
Should You Stay Away From Avon? Sep 30 2014 
comment on MED Mar 06 2013 
How Are GuruFocus Model Portfolios Faring Beside the Market in 2012? Dec 28 2012 
5-Star Predictable Companies with Highest ROA Mar 20 2012 
Medifast – 5-Star Predictability Rating Stock That Can Be Bought Cheaper Than Price Joel Greenblat Jan 12 2012 

More From Other Websites
MEDIFAST INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Feb 27 2015
Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal Year Ended December... Feb 26 2015
Medifast Joins Waterfront Partnership in Bringing Free Fitness Classes to the Inner Harbor Feb 23 2015
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medifast, Inc. Stockholders Feb 02 2015
Medco Energi Internasional Tbk (P.T.) -- Moody's withdraws Medco's B2 corporate family rating Jan 28 2015
Medifast Named SmartCEO Future 50 Award Winner for 4th Consecutive Year Jan 21 2015
MEDIFAST INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 13 2015
Medifast Launches New "Your Whole World Gets Better" Advertising Campaign Jan 08 2015
Medifast's New Year’s Resolution: Increase Revenue and Profits Jan 05 2015
[video]Medifast CEO: January Tracking Well, Clinic Closures Boosting Profits Jan 05 2015
Medifast, Inc. to Participate in the 17th Annual ICR XChange Conference Dec 30 2014
Medifast Board Member Barry B. Bondroff, CPA Becomes an NACD Fellow Dec 18 2014
Medifast Board Member Barry B. Bondroff, CPA Becomes an NACD Fellow Dec 18 2014
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medifast, Inc. Stockholders Dec 16 2014
Medifast's Meg Sheetz Named to Baltimore Business Journal's 40 Under 40 Dec 14 2014
MEDIFAST INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Material... Dec 11 2014
Medifast Launches New Energy Drops & Flavor Infusers™ Dec 09 2014
Medifast Launches New Energy Drops & Flavor Infusers™ Dec 09 2014
Medifast Implements Next Phase Of Weight Control Center Strategy Dec 05 2014
Medifast Implements Next Phase Of Weight Control Center Strategy Dec 05 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK